Table 1 Experimental setup.
From: Detection of acute ventilatory problems via magnetic induction in a newborn animal model
1. Induction of inhalation anesthesia with 2% isoflurane |
2. Placement of intravenous access at one ear |
3. Intravenous sedation with midazolame 0.1 mg/kg. Continuous infusion with ketamine (1 ml + 9 ml NaCl 0.9%): 0.6 ml/h → 6 mg/h, midazolame (purely) 0.6 ml/h → 3 mg/h. Monitoring using ECG and pulse oximetry at all four extremities |
4. Placement of second venous access at the other ear |
5. Intravenous parenteral dextrose infusion with Pädiafusin® I/Ringer®-Lsg. (Baxter, Unterschleißheim, Germany). Premedication for intubation with pentobarbital (1 ml + 15 ml NaCl 0.9%) 1 ml → 10 mg intravenously, fentanyl (1 ml + 9 ml NaCl) 2 ml → 10 mg intravenously |
6. Intubation with 3.5 mm endotracheal tube with surfactant channel up to tag 11 |
7. Initial ventilation via manual ventilation bag, then with respirator (frequency 40, p max 15, flow 8, PEEP 5), later p max 10 over 60 min |
8. Vital parameter measurement: conventional via ECG and pulse oximetry and via MIM. Measurement of arterial access with subsequent BGA monitoring of respiratory settings. Blood pressure monitoring via arterial access |
9. Malposition of endotracheal tube: ventilation of animal is stopped five times each for 1 min, while vital parameters are measured both conventionally and via MIM |
10. Atelectasis: the tube is introduced into the right lung → position check via X-ray. Synchronously, vital parameters are measured conventionally and by MIM in different positions. Thereafter, the “reopening” of the lung is documented via electrical impedance tomography if possible |
11. Pneumothorax: placement of an intrapleural catheter, position check via X-ray. Then, intrapleural insufflation of 20 ml of air → radiological check of the degree of pneumothorax |
12. Aspiration: 20 ml of NaCl 0.9% is applied intrapleurally and 10 ml is applied intrapulmonarily via surfactant channel |
13. Finalization of the animal experiment with 70 mg of pentobarbital intravenously |
During monitoring, as required: Bolus midazolame = 0.5 ml ≙ 0.5 mg Bolus ketamine = 0.4 ml ≙ 4 mg Bolus fentanyl = 2 ml ≙ 10 µg Bolus pentobarbital = 1 ml ≙ 10 mg |
Continuous infusion: 10 ml of ketamine in 50 ml (concentration 10 mg/ml); 10 ml midazolame in 50 ml (concentration 5 mg/ml) |
Bolus administration: • 20 ml syringe midazolame (concentration 1 mg/ml); 20 ml syringe ketamine (concentration 10 mg/ml) • 20 ml syringe fentanyl (concentration 5 µg/ml) • 20 ml syringe pentobarbital (concentration 10 mg/ml) • Midazolame (Dormicum®) (pure) 5 mg/ml® 1 ml + 4 ml NaCl 0.9% for 1 mg/ml • Ketamine (pure) 100 mg/ml® 1 ml + 9 ml NaCl 0.9% for 10 mg/ml • Fentanyl (pure) 50 µg/ml® 1 ml + 9 ml NaCl 0.9% for 5 µg/ml • Pentobarbital (Narcoren®) (pure) 160 mg/ml; 1 ml + 15 ml NaCl 0.9% for 10 mg/ml |